CD28 and COVID-19: HLA-A*24:02-positive PBMCs from COVID-19 mRNA vaccine recipients were cultured with T cell activators (CD3/CD28/CD2) and IL-2 for 10 days to expand T cell populations (Supplementary Table S3).